Widely Used Cardiac Surgery Drug Now Shown to Increase Risk of Death. Aprotinin — Shown to Cause Kidney Failure One Year Ago—Now Shown to Cause More Than 2,000 Deaths per Year In Today’s Journal of the American Medical Association – Tuesday, Februrary 06, 2007 - IREF_JAMA_Release.pdf

Widely Used Cardiac Surgery Drug Doubles Risk Of Kidney Failure. Aprotinin Proven Unsafe 13 Years After Approval In Today’s New England Journal of Medicine – Wednesday, January 25, 2006 – IREF_NEJM_Release.pdf

“The Risk of Aprotinin in Cardiac Surgery” New England Journal of Medicine – January 26, 2006 – factsheetfinal1-24-06.pdf

The Risk Associated with Aprotinin in Cardiac Surgery – Dennis T Mangano, Ph.D., M. D., Iulia C. Tudor, Ph.D., and Cynthia Dietzel, M.D., for the Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation – v354p353.pdf

The Value of Phase 4 Clinical Testing – Gus J. Vlahakes, M.D. – v354p413.pdf

First, Gather the Data – David Hunter, B.B., B.S. – v354p329.pdf